FDA PMA FDA Class 3 Approved 🇺🇸 United States

Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated

PMA: P160030 · Supplement: S017 · Decision Jul 23, 2018
Classifications
1
FEI Numbers
12
Registration Numbers
12

Basic Information

Device Name
Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated
Trade Name
FreeStyle Libre 14 Day Flash Glucose Monitoring System
PMA Number
P160030
Supplement Number
S017
Device Class
FDA Class 3
Product Code
PZE
Generic Name
Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
Approved
Decision Code
APPR
Decision Date
July 23, 2018
Date Received
April 10, 2018
Supplement Type
Panel Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N
Docket Number
18M-2886

Advisory Committee Statement

Approval for the FreeStyle Libre 14 Day Flash Glucose Monitoring System. The FreeStyle Libre 14 Day Flash Glucose Monitoring System is a continuous glucose monitoring (CGM) device indicated for the management of diabetes in persons age 18 and older. It is designed to replace blood glucose testing for diabetes treatment decisions. The System detects trends and tracks patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. Interpretation of the System readings should be based on the glucose trends and several sequential readings over time. The System is intended for single patient use and requires a prescription.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PZE Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated